CXCL12 and neoplasm: In addition, the lymphatic endothelial cells produce chemokines such as the stromal-derived factor 1 (or CXCL12), which bind CXCR4 receptors in the tumor cells [17, 18], facilitating their migration toward the lymphatic vessel [19].